MD Anderson Research Highlights Special Edition: ESMO 2024
September 11, 2024
September 11, 2024
HOUSTON, Texas, Sept. 11 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following research highlight:
* * *
Featuring promising novel immunotherapies and targeted therapies, predictive biomarkers, and insights into COVID mRNA vaccines and immunotherapy responses
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical cancer researc . . .
* * *
Featuring promising novel immunotherapies and targeted therapies, predictive biomarkers, and insights into COVID mRNA vaccines and immunotherapy responses
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical cancer researc . . .